Structure, function and antagonists of urokinase-type plasminogen activator

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Urokinase (uPA) is a serine protease converting plasminogen to plasmin, activating extracellular matrix degradation.
• uPA's modular structure comprises growth factor-like, kringle, and serine protease domains, linked by a connecting peptide.
• uPA's role in cancer invasion and metastasis is well-established, driving interest in therapeutic blockade.

Purpose of the Study:

• To review the structure-function relationship of urokinase (uPA) domains.
• To explore novel therapeutic strategies targeting uPA interactions and activity.
• To summarize recent findings on uPA inhibitors, particularly those derived from the connecting peptide.

Main Methods:

• Literature review of scientific publications on uPA structure, function, and inhibition.
• Analysis of molecular interactions involving uPA domains and receptors.
• Compilation of data on existing and emerging uPA inhibitors.

Main Results:

• The function of individual uPA domains is not fully elucidated, despite known interactions with uPA receptor and integrins.
• The interdomain linker or connecting peptide (CP) is emerging as a key target for novel uPA inhibitors.
• Existing inhibitors target various uPA functions, with new strategies focusing on CP-derived molecules.

Conclusions:

• Understanding uPA domain functions is critical for developing effective cancer therapies.
• Inhibitors targeting the uPA connecting peptide show significant potential for blocking cancer invasion and metastasis.
• Further research into uPA inhibitors is essential for advancing novel cancer treatment strategies.